Brain injury, neuroinflammation and Alzheimer's disease

被引:75
|
作者
Breunig, Joshua J. [1 ,2 ]
Guillot-Sestier, Marie-Victoire [3 ]
Town, Terrence [3 ]
机构
[1] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA
[3] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA
来源
基金
美国国家卫生研究院;
关键词
traumatic brain injury; Alzheimer disease; neuroinflammation; chronic traumatic encephalopathy; tauopathy; amyloid-beta peptides; neuronal loss; transgenic rat model; AMYLOID PRECURSOR PROTEIN; APOPTOTIC CELL-DEATH; CEREBRAL BETA-AMYLOIDOSIS; TRAUMA-INDUCED INCREASES; LONG-TERM ACCUMULATION; CORTICAL IMPACT INJURY; NECROSIS-FACTOR-ALPHA; AXONAL INJURY; A-BETA; CEREBROSPINAL-FLUID;
D O I
10.3389/fnagi.2013.00026
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
With as many as 300,000 United States troops in Iraq and Afghanistan having suffered head injuries (Miller, 2012), traumatic brain injury (TBI) has garnered much recent attention. While the cause and severity of these injuries is variable, severe cases can lead to lifelong disability or even death. While aging is the greatest risk factor for Alzheimer's disease (AD), it is now becoming clear that a history of TBI predisposes the individual to AD later in life (Sivanandam and Thakur, 2012). In this review article, we begin by defining hallmark pathological features of AD and the various forms of TBI. Putative mechanisms underlying the risk relationship between these two neurological disorders are then critically considered. Such mechanisms include precipitation and 'spreading' of cerebral amyloid pathology and the role of neuroinflammation. The combined problems of TBI and AD represent significant burdens to public health. A thorough, mechanistic understanding of the precise relationship between TBI and AD is of utmost importance in order to illuminate new therapeutic targets. Mechanistic investigations and the development of preclinical therapeutics are reliant upon a clearer understanding of these human diseases and accurate modeling of pathological hallmarks in animal systems.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Updates on the association of brain injury and Alzheimer's disease
    Klomparens, Kara
    Ding, Yuchuan
    [J]. BRAIN CIRCULATION, 2020, 6 (02) : 65 - 69
  • [22] The impact of systemic infection on neuroinflammation in human brain affected by Alzheimer's disease
    Rakic, S.
    Nicoll, J. A. R.
    Love, S.
    Holmes, C.
    Perry, V. H.
    Stewart, W.
    Boche, D.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 : 32 - 33
  • [23] Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation
    Testa, Gabriella
    Staurenghi, Erica
    Zerbinati, Chiara
    Gargiulo, Simona
    Iuliano, Luigi
    Giaccone, Giorgio
    Fanto, Fausto
    Poli, Giuseppe
    Leonarduzzi, Gabriella
    Gamba, Paola
    [J]. REDOX BIOLOGY, 2016, 10 : 24 - 33
  • [24] Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease
    De Felice, Fernanda G.
    Lourenco, Mychael V.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [25] The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur, Ashwinipriyadarshini
    Baltriukiene, Daiva
    Bukelskiene, Virginija
    Burokas, Aurelijus
    [J]. NUTRIENTS, 2021, 13 (01) : 1 - 24
  • [26] Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease
    Lee, Rae-Ling
    Funk, Kristen E.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [27] Targeting Neuroinflammation to Treat Alzheimer's Disease
    Ardura-Fabregat, A.
    Boddeke, E. W. G. M.
    Boza-Serrano, A.
    Brioschi, S.
    Castro-Gomez, S.
    Ceyzeriat, K.
    Dansokho, C.
    Dierkes, T.
    Gelders, G.
    Heneka, Michael T.
    Hoeijmakers, L.
    Hoffmann, A.
    Iaccarino, L.
    Jahnert, S.
    Kuhbandner, K.
    Landreth, G.
    Lonnemann, N.
    Loeschmann, P. A.
    McManus, R. M.
    Paulus, A.
    Reemst, K.
    Sanchez-Caro, J. M.
    Tiberi, A.
    Van der Perren, A.
    Vautheny, A.
    Venegas, C.
    Webers, A.
    Weydt, P.
    Wijasa, T. S.
    Xiang, X.
    Yang, Y.
    [J]. CNS DRUGS, 2017, 31 (12) : 1057 - 1082
  • [28] The significance of neuroinflammation in understanding Alzheimer's disease
    Eikelenboom, P.
    Veerhuis, R.
    Scheper, W.
    Rozemuller, A. J. M.
    van Gool, W. A.
    Hoozemans, J. J. M.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) : 1685 - 1695
  • [29] Targeting Neuroinflammation to Treat Alzheimer’s Disease
    A. Ardura-Fabregat
    E. W. G. M. Boddeke
    A. Boza-Serrano
    S. Brioschi
    S. Castro-Gomez
    K. Ceyzériat
    C. Dansokho
    T. Dierkes
    G. Gelders
    Michael T. Heneka
    L. Hoeijmakers
    A. Hoffmann
    L. Iaccarino
    S. Jahnert
    K. Kuhbandner
    G. Landreth
    N. Lonnemann
    P. A. Löschmann
    R. M. McManus
    A. Paulus
    K. Reemst
    J. M. Sanchez-Caro
    A. Tiberi
    A. Van der Perren
    A. Vautheny
    C. Venegas
    A. Webers
    P. Weydt
    T. S. Wijasa
    X. Xiang
    Y. Yang
    [J]. CNS Drugs, 2017, 31 : 1057 - 1082
  • [30] Insulin resistance, neuroinflammation, and Alzheimer's disease
    Najem, Dema
    Bamji-Mirza, Michelle
    Chang, Nina
    Liu, Qing Yan
    Zhang, Wandong
    [J]. REVIEWS IN THE NEUROSCIENCES, 2014, 25 (04) : 509 - 525